Clinical Trial Update: Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer [Phase 3]

View source ↗

Summary

Phase 3 efficacy trial comparing nivolumab plus ipilimumab or nivolumab plus chemotherapy against standard chemotherapy in gastric cancer and gastroesophageal j…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-06-28